Hi everyone,

Thanks to your continued support, we’ve reached 172 signatures! ! Every signature, share, and conversation is helping shine a light on an urgent issue: Canada’s failure to provide access to essential COVID-19 protections for those who need them most.

Here’s What’s New:

1. COVID-19 Activity Is Rising Again — Even in Summer

Wastewater surveillance across every province confirms a rise in viral activity. COVID-19 is not seasonal, and our protective tools can’t be seasonal either. Immunocompromised people need year-round access to updated vaccines and monoclonal antibodies.

2. Pemgarda (Pemivibart) Still Unavailable

Despite its Emergency Use Authorization in the U.S. and proven neutralization of circulating variants, Pemgarda remains out of reach in Canada. Health Canada lacks an emergency-use pathway like the FDA’s—leaving patients without access while Invivyd focuses on future-generation antibodies like VYD2311.

We continue to urge Health Canada to adopt a more flexible regulatory framework to allow emergency access to Pemgarda, just as the U.S. has done.

3. Kavigale (Sipavibart) Approved — But Withheld

Health Canada has granted a Notice of Compliance (NOC) for Kavigale (sipavibart injection) for pre-exposure prophylaxis of COVID-19 in high-risk immunocompromised individuals. This decision was based on the SUPERNOVA1 trial, which showed a statistically significant reduction in symptomatic COVID-19 in this population.

However, AstraZeneca has decided not to launch Kavigale in Canada at this time, citing that less than 5% of current SARS-CoV-2 variants are susceptible to it. They’ve stated they will continue to monitor variant trends and may reconsider this decision if susceptibility rises.

As a result, our efforts are best focused on securing access to Pemgarda, which has demonstrated neutralizing activity against circulating variants and already has Emergency Use Authorization in the U.S.

We urge Health Canada and Canadian policymakers to:

• Prioritize a pathway for emergency access to Pemgarda

• Act urgently to protect those at highest risk

This campaign isn’t just about a medication—it’s about equity, dignity, and the right to protection. Thank you for continuing to stand with immunocompromised Canadians.

Thank you for your support,
Rowan

Disclaimer: This update is for informational and advocacy purposes only and does not constitute medical or legal advice. For medical guidance, please consult a qualified healthcare provider. References to medications or regulatory processes do not imply endorsement or official affiliation with any companies or health agencies.